original ) (raw )Cyclic nucleotide phosphodiesterase type 4 inhibitors: Evaluation of pyrazolo[1,5-a]-1,3,5-triazine ring system as an adenine bioisostere
Philippe Bernard
European Journal of Medicinal Chemistry, 2008
View PDFchevron_right
cAMP-dependent phosphodiesterase inhibition and SAR studies on novel 6,8-disubstituted 2-phenyl-3-(substituted benzothiazole-2-yl)-4[3H]-quinazolinone
Dr Sachin S Laddha
Medicinal Chemistry Research, 2009
View PDFchevron_right
Synthesis and evaluation of quinazoline derivatives as phosphodiesterase 7 inhibitors
Julio Alvarez-Builla
Bioorganic & Medicinal Chemistry, 2013
View PDFchevron_right
Synthesis and SAR study of new phenylimidazole-pyrazolo[1,5-c]quinazolines as potent phosphodiesterase 10A inhibitors
Battistina Asproni , Gabriele Murineddu
Bioorganic & Medicinal Chemistry, 2011
View PDFchevron_right
Synthesis and In Vitro Evaluation of 8-Pyridinyl-Substituted Benzo[e]imidazo[2,1-c][1,2,4]triazines as Phosphodiesterase 2A Inhibitors
RIEN RITAWIDYA
Molecules
View PDFchevron_right
www.ijcrcps.com Research Article 5-CHLORO-1-(4-PIPERIDYL)-2-BENZIMIDAZOLINONE DERIVATIVES, AS POTENT PHOSPHODIESTERASE AND Α-GLUCOSIDASE INHIBITORS
Shazia Haider
2015
View PDFchevron_right
Design, synthesis and evaluation of N2,N4-diaminoquinazoline based inhibitors of phosphodiesterase type 5
Nattakarn Pobsuk
Bioorganic & Medicinal Chemistry Letters, 2018
View PDFchevron_right
Quinazolines: Combined type 3 and 4 phosphodiesterase inhibitors
Reto Naef
Bioorganic & Medicinal Chemistry Letters, 1998
View PDFchevron_right
Synthesis, Structural Analysis, and Biological Evaluation of Thioxoquinazoline Derivatives as Phosphodiesterase 7 Inhibitors
Sara Ballester
ChemMedChem, 2009
View PDFchevron_right
Inhibitors of blood platelet cAMP phosphodiesterase. 2. Structure-activity relationships associated with 1,3-dihydro-2H-imidazo[4,5-b]quinolin-2-ones substituted with functionalized side chains
nicholas meanwell
Journal of Medicinal Chemistry, 1992
View PDFchevron_right
Discovery of novel pyrazolopyrimidinone analogs as potent inhibitors of phosphodiesterase type-5
Subhash Sharma
Bioorganic & Medicinal Chemistry, 2015
View PDFchevron_right
1-(2-(2,2,2-Trifluoroethoxy)ethyl-1H-pyrazolo[4,3-d]pyrimidines as potent phosphodiesterase 5 (PDE5) inhibitors
David Fox
Bioorganic & Medicinal Chemistry Letters, 2010
View PDFchevron_right
Synthesis and Evaluation of Polycyclic Pyrazolo[3,4-d]pyrimidines as PDE1 and PDE5 cGMP Phosphodiesterase Inhibitors
Robert Watkins
Journal of Medicinal Chemistry, 1997
View PDFchevron_right
Synthesis and Structure-Activity Relationships of Aza- and Diazabiphenyl Analogues of the Antitubercular Drug (6S)-2-Nitro-6-{[4-(trifluoromethoxy)benzyl]oxy}-6,7-dihydro-5H-imidazo[2,1-b][1,3]oxazine (PA-824)
Iveta Kmentova
Journal of Medicinal Chemistry, 2010
View PDFchevron_right
Synthesis of phosphodiesterase IVb inhibitors 2. Stereoselective synthesis of hexahydro-3H-pyrrolo[1,2-c]imidazol-3-one and tetrahydro-1H-pyrrolo[1,2-c][1,3]oxazol-3-one derivatives
Alexey Sukhorukov
Russian Chemical Bulletin, 2011
View PDFchevron_right
Synthesis and in vitro evaluation of new analogues as inhibitors for phosphodiesterase 10A
Robert Mach
European Journal of Medicinal Chemistry, 2011
View PDFchevron_right
Safety and Efficacy of New 3,6-diaryl-7H-[1,2,4]triazolo[3,4-b][1,3,4]thiadiazine Analogs as Potential Phosphodiesterase-4 Inhibitors in NIH-3T3 Mouse Fibroblastic Cells
maryam motamedi
Chemical Biology & Drug Design, 2011
View PDFchevron_right
The selective inhibition of phosphodiesterase IV by benzopyran derivatives of rolipram
Ivan A Pinto CC
Bioorganic & Medicinal Chemistry Letters, 1993
View PDFchevron_right
Discovery of Potent and Selective Periphery-Restricted Quinazoline Inhibitors of the Cyclic Nucleotide Phosphodiesterase PDE1
Jennifer Liras
Journal of medicinal chemistry, 2018
View PDFchevron_right
Ultrasound One Pot Synthesis of Fused Quinazolinones and Quinazolinediones, Screening and Molecular Docking Study as Phosphodiesterase 7A Inhibitors Egyptian Journal of Chemistry http://ejchem.journals.ekb.eg
Sherin Feky
Egyptian Journal of Chemistry, 2019
View PDFchevron_right
Structural Basis for the Activity of Drugs that Inhibit Phosphodiesterases
Prabha Ibrahim
Structure, 2004
View PDFchevron_right
Design, synthesis, and biological activity of certain quinazolinedione derivatives as potent phosphodiestrase4 inhibitors
Eman Ahmed
Medicinal Chemistry Research, 2012
View PDFchevron_right
Synthesis and Anticholinesterase Activity and Cytotoxicity of Novel Amide Derivatives
Ahmet Ozdemir
Archiv der Pharmazie, 2012
View PDFchevron_right
Ultrasound one pot synthesis of fused quinazolinones and quinazolinediones, screening and molecular docking study as phosphodiesterase 7A inhibitors
Sherin Feky
Egyptian Journal of Chemistry
View PDFchevron_right
Discovery of a new series of [1,2,4]triazolo[4,3-a]quinoxalines as dual phosphodiesterase 2/phosphodiesterase 10 (PDE2/PDE10) inhibitors
Andres Trabanco
Bioorganic & Medicinal Chemistry Letters, 2013
View PDFchevron_right
Synthesis and pharmacological assessment of diversely substituted pyrazolo[3,4- b]quinoline, and benzo[ b]pyrazolo[4,3- g][1,8]naphthyridine derivatives
Abdelouahid Samadi
European Journal of Medicinal Chemistry, 46, 4676-4681, 2011, 2011
View PDFchevron_right
Synthesis and biological activity of tricyclic cycloalkylimidazo-, pyrimido- and diazepinopurinediones
Katarzyna Karcz
European Journal of Medicinal Chemistry, 2011
View PDFchevron_right
Discovery of clinical candidate 1-(4-(3-(4-(1H-benzo[d]imidazole-2-carbonyl)phenoxy)pyrazin-2-yl)piperidin-1-yl)ethanone (AMG 579), a potent, selective, and efficacious inhibitor of phosphodiesterase 10A (PDE10A)
Ji Ma
Journal of medicinal chemistry, 2014
View PDFchevron_right
Synthesis, Docking Studies, Pharmacological Activity and Toxicity of a Novel Pyrazole Derivative (LQFM 021)—Possible Effects on Phosphodiesterase
Luciano Lião
Chemical and Pharmaceutical Bulletin, 2013
View PDFchevron_right